ATE230984T1 - Klare injizierbare formulierung einer anästhetischen verbindung - Google Patents

Klare injizierbare formulierung einer anästhetischen verbindung

Info

Publication number
ATE230984T1
ATE230984T1 AT98932068T AT98932068T ATE230984T1 AT E230984 T1 ATE230984 T1 AT E230984T1 AT 98932068 T AT98932068 T AT 98932068T AT 98932068 T AT98932068 T AT 98932068T AT E230984 T1 ATE230984 T1 AT E230984T1
Authority
AT
Austria
Prior art keywords
aesthetic
compound
injectable formulation
clear
clear injectable
Prior art date
Application number
AT98932068T
Other languages
English (en)
Inventor
Tommaso Vincenzo De
Original Assignee
Westy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Westy Ag filed Critical Westy Ag
Application granted granted Critical
Publication of ATE230984T1 publication Critical patent/ATE230984T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT98932068T 1997-05-26 1998-05-14 Klare injizierbare formulierung einer anästhetischen verbindung ATE230984T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01224/97A CH692322A5 (it) 1997-05-26 1997-05-26 Formulazione iniettabile limpida di Propofol.
PCT/EP1998/003004 WO1998053805A1 (en) 1997-05-26 1998-05-14 Clear, injectable formulation of an anesthetic compound

Publications (1)

Publication Number Publication Date
ATE230984T1 true ATE230984T1 (de) 2003-02-15

Family

ID=4205400

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932068T ATE230984T1 (de) 1997-05-26 1998-05-14 Klare injizierbare formulierung einer anästhetischen verbindung

Country Status (23)

Country Link
US (1) US6326406B1 (de)
EP (1) EP0991405B1 (de)
JP (1) JP2001527577A (de)
KR (1) KR20010013011A (de)
CN (1) CN1268051A (de)
AR (1) AR012853A1 (de)
AT (1) ATE230984T1 (de)
AU (1) AU735020B2 (de)
BR (1) BR9809492A (de)
CA (1) CA2291261A1 (de)
CH (1) CH692322A5 (de)
DE (1) DE69810771D1 (de)
DZ (1) DZ2503A1 (de)
HU (1) HUP0002117A3 (de)
IN (1) IN187550B (de)
MY (1) MY132911A (de)
NO (1) NO995831L (de)
PA (1) PA8451701A1 (de)
PE (1) PE75299A1 (de)
PL (1) PL337026A1 (de)
TR (1) TR200000116T2 (de)
WO (1) WO1998053805A1 (de)
ZA (1) ZA984314B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6749868B1 (en) 1993-02-22 2004-06-15 American Bioscience, Inc. Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
CN1151782C (zh) * 1999-01-28 2004-06-02 迪内希·尚蒂拉尔·帕特尔 一种具有哺乳动物麻醉的诱导和保持以及镇静用途的药用注射液
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6635456B2 (en) * 2001-02-09 2003-10-21 Fidia Farmaceutici S.P.A. Procedure for the preparation of pure phosphatides with phospholipase D
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
KR100482269B1 (ko) * 2002-10-08 2005-04-14 센츄론(주) 2,6-디이소프로필페놀을 활성성분으로 하는 수용액상의마취용 주사제 및 그 제조방법
LT1585548T (lt) * 2002-12-09 2018-09-25 Abraxis Bioscience, Llc Farmakologinių agentų kompozicijos ir įvedimo būdai
US20040225022A1 (en) * 2003-05-09 2004-11-11 Desai Neil P. Propofol formulation containing reduced oil and surfactants
US8476010B2 (en) 2003-07-10 2013-07-02 App Pharmaceuticals Llc Propofol formulations with non-reactive container closures
US8546453B2 (en) 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
JP2005154305A (ja) * 2003-11-21 2005-06-16 Showa Yakuhin Kako Kk ヒアルロン酸含有組成物の製造方法
CN100358513C (zh) * 2005-04-07 2008-01-02 常州市第四制药厂有限公司 一种丙泊酚注射液的制备工艺
DK1931321T3 (en) 2005-08-31 2019-04-15 Abraxis Bioscience Llc COMPOSITIONS CONTAINING VERY WATER-SOLUBLE PHARMACEUTICAL AND ANTIMICROBIAL AGENTS
CA2620389C (en) 2005-08-31 2014-06-17 Abraxis Bioscience, Llc Compositions and methods for preparation of poorly water soluble drugs with increased stability
AU2009316624B2 (en) * 2008-11-20 2013-03-14 Techno Guard Co., Ltd. Pyrazolone Derivative Formulations
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
CA3088017A1 (en) * 2018-03-07 2019-09-12 Andrew Xian Chen Aqueous formulations for insoluble drugs
JP7135670B2 (ja) * 2018-09-27 2022-09-13 住友電気工業株式会社 光ファイバ及び紫外線硬化型樹脂組成物
JP7063217B2 (ja) * 2018-09-27 2022-05-09 住友電気工業株式会社 光ファイバの製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1089510B (de) 1959-03-23 1960-09-22 Rudolf Reiss Dr Verfahren zur Herstellung waessriger, injizierbarer Loesungen von 2-Methoxy-4-allylphenoxyessigsaeure-N, N-Diaethylamid
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1472793A (en) * 1974-03-28 1977-05-04 Ici Ltd Pharmaceutical compositions
DE3221579A1 (de) 1982-06-08 1983-12-22 Eckert, Theodor, Prof. Dr., 4400 Münster Solubilisierung von in wasser schwerloeslichen wirkstoffen in waessrige loesung unter verwendung eines gemisches von cholinphosphorsaeureglycerindiester (cholin-lecithin) und natriumdesoxycholat als loesungsvermittler und die therapeutische verwendung der so erhaltenen waessrigen loesungen
CA1319886C (en) 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions
US5085864A (en) * 1989-10-30 1992-02-04 Abbott Laboratories Injectable formulation for lipophilic drugs
DE4039602A1 (de) * 1990-12-12 1992-06-17 Bauer Kurt Heinz Prof Dr Pharmazeutische formulierungen
GB9405593D0 (en) 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
WO1997010814A1 (en) * 1995-09-18 1997-03-27 Vesifact Ag Propofol nanodispersions
US5637625A (en) * 1996-03-19 1997-06-10 Research Triangle Pharmaceuticals Ltd. Propofol microdroplet formulations

Also Published As

Publication number Publication date
DZ2503A1 (fr) 2005-01-25
CA2291261A1 (en) 1998-12-03
WO1998053805A1 (en) 1998-12-03
HUP0002117A3 (en) 2001-04-28
KR20010013011A (ko) 2001-02-26
PL337026A1 (en) 2000-07-31
PA8451701A1 (es) 2000-05-24
IN187550B (de) 2002-05-18
PE75299A1 (es) 1999-08-26
BR9809492A (pt) 2000-06-20
CN1268051A (zh) 2000-09-27
JP2001527577A (ja) 2001-12-25
AR012853A1 (es) 2000-11-22
AU735020B2 (en) 2001-06-28
EP0991405B1 (de) 2003-01-15
ZA984314B (en) 1998-12-08
NO995831D0 (no) 1999-11-26
DE69810771D1 (de) 2003-02-20
MY132911A (en) 2007-10-31
CH692322A5 (it) 2002-05-15
NO995831L (no) 2000-01-26
HUP0002117A2 (hu) 2000-12-28
EP0991405A1 (de) 2000-04-12
AU8209798A (en) 1998-12-30
TR200000116T2 (tr) 2000-05-22
US6326406B1 (en) 2001-12-04

Similar Documents

Publication Publication Date Title
ATE230984T1 (de) Klare injizierbare formulierung einer anästhetischen verbindung
CY2007028I1 (el) Παραγωγα πλευρομουτιλινης σαν αντιμικροβιακα
PT966430E (pt) Compostos anti-inflamatorios
DE69840618D1 (de) Radargerät
DE69837906D1 (de) Insektizides proteintoxin von xenorhabus
DE69941116D1 (de) G von gdf-8
DE69618775D1 (de) Wässrige beschichtungszusammensetzungen
NO20001631L (no) 2-metyl-tieno-benzodiazepin formulering
DE69804950D1 (de) Gelenkverbindung
DE69835817D1 (de) Eutektische verbindung von einkristallinen komponenten
DE69632283D1 (de) Wässrige Lackzusammensetzung
DE69603707D1 (de) Wässrige anstrichzusammensetzung
DE69807976D1 (de) Zusammensetzung einer Glaspaste
DE69822366D1 (de) Wässrige Emulsionszusammensetzung
ID24677A (id) Kombinasi senyawa aktif fungisidal
DE69307306T2 (de) Wässrige überzugszusammensetzungen
ID23928A (id) Formulasi mengandung insektisida
EE9900541A (et) Toiduhappe tootmine
NO995839L (no) Substituerte cyklobutylamin-derivater
FI953106A (fi) Difuoripentapeptidijohdannaiset anti-inflammatorisina aineina
DE29717661U1 (de) Verbindung von Kernen
DE59906087D1 (de) Wässerige Zubereitung von Beta-Carotin
PT850246E (pt) Derivados nucleosidicos de pirimidina
NO994977D0 (no) Fremstilling av enantiomerfrie biarylketokarboksylsyrer
DE69812108T2 (de) Pestizide zusammensetzung in form einer wässerigen suspension

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties